First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration

Summary

The purpose of this first-in-human study is to assess the local ocular and systemic safety and tolerability of LHA510 eye drops when administered at various concentrations and dosing frequencies.

Timeline

Start

2014-02

Primary completion

2014-06

Completion

2014-06

Drugs

Indications